Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research, Inc. | PRODUCT CODE: 1122301

Cover Image

PUBLISHER: Grand View Research, Inc. | PRODUCT CODE: 1122301

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain, Others), By Animal Type (Dogs, Others), By End User (Veterinary Hospitals, Others), By Region, & Segment Forecasts, 2022 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Monoclonal Antibodies In Veterinary Health Market Growth & Trends:

The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.67 billion by 2030 expanding at a CAGR of 16.7% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis is also likely to drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn is relatively lower in the animal health market as compared to others. There will be a shift in business models for veterinarians. Traditional veterinary practices generate a majority of their revenues from selling high-margin products like pharmaceuticals.

The growing incidence of cancer, especially in dogs, is anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 in 4 dogs are expected to suffer from neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of the treatment of neoplasia in dogs. This can also be catered to using monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis invested in new manufacturing and development facility in Ireland, to increase its Monoclonal Antibodies (mAbs) production capabilities. This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company's access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

Monoclonal Antibodies In Veterinary Health Market Report Highlights:

  • In terms of revenue, the dogs' segment dominated the animal type segment with a share in 2021 owing to the growing adoption of dogs as pets
  • Based on the application, the dermatology segment is expected to account for the largest market share of over 55% owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospitals' segment is expected to account for the dominant market share owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North American region is anticipated to account for the largest market share of around 44% owing to the presence of major market players in the region
Product Code: GVR-4-68039-973-5

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
  • 1.7 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Monoclonal Antibodies in Veterinary Health Market Summary

Chapter 3 Monoclonal Antibodies in Veterinary Health Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Penetration & Growth Prospect Mapping, 2021
  • 3.3 Monoclonal Antibodies in Veterinary Health Market Dynamics
    • 3.3.1 Market driver analysis
    • 3.3.2 Market restraint analysis
    • 3.3.3 Market opportunity analysis
    • 3.3.4 Market challenge analysis
  • 3.4 Monoclonal Antibodies in Veterinary Health Market Analysis Tools: Porter's
    • 3.4.1 Supplier Power
    • 3.4.2. Buyer Power
    • 3.4.3. Substitution Threat
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Competitive Rivalry
  • 3.5 Monoclonal Antibodies in Veterinary Health Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
    • 3.5.1 Political/Legal Landscape
    • 3.5.2 Economic Landscape
    • 3.5.3 Social Landscape
    • 3.5.4 Technology Landscape
  • 3.6 Regulatory Framework
  • 3.7 Product Pipeline Analysis
  • 3.8 COVID -19 Impact Analysis
    • 3.8.1 Current and Future Impact Analysis
    • 3.8.2. Impact On Market Players

Chapter 4 Monoclonal Antibodies in Veterinary Health Market: Segment Analysis, By Animal Type, 2017 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Animal Type Market Share Analysis, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Monoclonal Antibodies in Veterinary Health Market, by Animal Type, 2017 to 2030
  • 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 4.5.1. Dogs
      • 4.5.1.1 Dogs market, 2017 - 2030 (USD Million)
    • 4.5.2. Others
      • 4.5.2.1 Others market, 2017 - 2030 (USD Million)

Chapter 5 Monoclonal Antibodies in Veterinary Health Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Application Market Share Analysis, 2021 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Monoclonal Antibodies in Veterinary Health Market, by Application, 2017 to 2030
  • 5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 5.5.1. Dermatology
      • 5.5.1.1 Dermatology market, 2017 - 2030 (USD Million)
    • 5.5.2. Pain
      • 5.5.2.1 Pain market, 2017 - 2030 (USD Million)
    • 5.5.3. Others
      • 5.5.3.1 Others market, 2017 - 2030 (USD Million)

Chapter 6 Monoclonal Antibodies in Veterinary Health Market: Segment Analysis, By End-User, 2017 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. End-User Market Share Analysis, 2021 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Monoclonal Antibodies in Veterinary Health Market, by End-User, 2017 to 2030
  • 6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
    • 6.5.1. Veterinary Hospitals
      • 6.5.1.1 Veterinary Hospitals market, 2017 - 2030 (USD Million)
    • 6.5.2. Others
      • 6.5.2.1 Others market, 2017 - 2030 (USD Million)

Chapter 7 Monoclonal Antibodies in Veterinary Health Market: Regional Market Analysis 2017 - 2030 (USD Million)

  • 7.1. Definitions & Scope
  • 7.2. Regional Market Share Analysis, 2021 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030:
  • 7.5. North America
    • 7.5.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada Monoclonal Antibodies in Veterinary Health Market estimates and forecast, by product, 2017 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Germany Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.6.4. U.K.
      • 7.6.4.1 U.K. Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Italy Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.6.6. France
      • 7.6.6.1. France Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.6.7. Spain
      • 7.6.7.1. Spain Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 7.7.2. India
      • 7.7.2.1. India Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. China Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.7.4. Japan
      • 7.7.4.1. Japan Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Australia Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. South Korea Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Brazil Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.8.3. Mexico
      • 7.8.3.1. Mexico Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.8.4. Argentina
      • 7.8.4.1. Argentina Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • 7.9. Middle East and Africa
    • 7.9.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. South Africa Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)

Chapter 8 Monoclonal Antibodies in Veterinary Health Market - Competitive Analysis

  • 8.1 Market Participant Categorization
    • 8.1.1. Company Market Position Analysis
    • 8.1.2. Synergy Analysis: Major Deals & Strategic Alliances
    • 8.1.3. Market Leaders & Innovators
  • 8.2. List of Key Companies and Emerging players

Chapter 9 Monoclonal Antibodies in Veterinary Health Market - Company Profiles

  • 9.1 Merck & Co., Inc.
    • 9.1.1 Company overview
    • 9.1.2 Financial performance
    • 9.1.3 Product benchmarking/ Pipeline
    • 9.1.4 Strategic initiatives
  • 9.2 Zoetis
    • 9.2.1 Company overview
    • 9.2.2 Financial performance
    • 9.2.3 Product benchmarking/ Pipeline
    • 9.2.4 Strategic initiatives
  • 9.3. Boehringer Ingelheim GmbH
    • 9.3.1 Company overview
    • 9.3.2 Financial performance
    • 9.3.3 Product benchmarking/ Pipeline
    • 9.3.4 Strategic initiatives
  • 9.4 Elanco
    • 9.4.1 Company overview
    • 9.4.2 Financial performance
    • 9.4.3 Product benchmarking/ Pipeline
    • 9.4.4 Strategic initiatives
  • 9.5 Indian Immunologicals Ltd
    • 9.5.1 Company overview
    • 9.5.2 Financial performance
    • 9.5.3 Product benchmarking/ Pipeline
    • 9.5.4 Strategic initiatives
  • 9.6 Virbac
    • 9.6.1 Company overview
    • 9.6.2 Financial performance
    • 9.6.3 Product benchmarking/ Pipeline
    • 9.6.4 Strategic initiatives
Product Code: GVR-4-68039-973-5

List of Tables

  • Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by region, 2017 - 2030 (USD Million)
  • Table 2 North America Monoclonal Antibodies in Veterinary Health Market, By Region, 2017 - 2030 (USD Million)
  • Table 3 North America Monoclonal Antibodies in Veterinary Health Market, by animal type, 2017 - 2030 (USD Million)
  • Table 4 North America Monoclonal Antibodies in Veterinary Health Market, by application, 2017 - 2030 (USD Million)
  • Table 5 North America Monoclonal Antibodies in Veterinary Health Market, by end-user, 2017 - 2030 (USD Million)
  • Table 6 US Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 7 US Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 8 US Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 9 Canada Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 10 Canada Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 11 Canada Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 12 Europe Monoclonal Antibodies in Veterinary Health Market, By Region, 2017 - 2030 (USD Million)
  • Table 13 Europe Monoclonal Antibodies in Veterinary Health Market, by animal type, 2017 - 2030 (USD Million)
  • Table 14 Europe Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 15 Europe Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 16 Germany Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 17 Germany Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 18 Germany Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 19 U.K. Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 20 U.K. Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 21 U.K. Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 22 Spain Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 23 Spain Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 24 Spain Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 25 Italy Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 26 Italy Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 27 Italy Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 28 France Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 29 France Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 30 France Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 31 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, By Region, 2017 - 2030 (USD Million)
  • Table 32 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, by animal type, 2017 - 2030 (USD Million)
  • Table 33 Asia Pacific Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 34 Asia Pacific Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 35 Japan Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 36 Japan Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 37 Japan Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 38 China Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 39 China Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 40 China Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 41 India Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 42 India Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 43 India Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 44 Australia Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 45 Australia Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 46 Australia Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 47 South Korea Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 48 South Korea Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 49 South Korea Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 50 LATAM Monoclonal Antibodies in Veterinary Health Market, By Region, 2017 - 2030 (USD Million)
  • Table 51 LATAM Monoclonal Antibodies in Veterinary Health Market, by animal type, 2017 - 2030 (USD Million)
  • Table 52 LATAM Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 53 LATAM Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 54 Brazil Monoclonal Antibodies in Veterinary Health Market, by animal type, 2017 - 2030 (USD Million)
  • Table 55 Brazil Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 56 Brazil Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 57 Mexico Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 58 Mexico Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 59 Mexico Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 60 Argentina Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 61 Argentina Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 62 Argentina Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 63 MEA Monoclonal Antibodies in Veterinary Health Market, By Region, 2017 - 2030 (USD Million)
  • Table 64 MEA Monoclonal Antibodies in Veterinary Health Market, by animal type, 2017 - 2030 (USD Million)
  • Table 65 MEA Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 66 MEA Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 67 South Africa Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 68 South Africa Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 69 South Africa Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)
  • Table 70 Saudi Arabia Monoclonal Antibodies in Veterinary Health market, by animal type, 2017 - 2030 (USD Million)
  • Table 71 Saudi Arabia Monoclonal Antibodies in Veterinary Health market, by application, 2017 - 2030 (USD Million)
  • Table 72 Saudi Arabia Monoclonal Antibodies in Veterinary Health market, by end-user, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Monoclonal Antibodies in Veterinary Health Market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Ansoff's matrix analysis
  • Fig. 15 Heat map analysis
  • Fig. 16 Market penetration vs growth prospect mapping
  • Fig. 17 Market share of key market players- Monoclonal Antibodies in Veterinary Health Market
  • Fig. 18 Strategy mapping
  • Fig. 19 Monoclonal Antibodies in Veterinary Health Market animal type outlook: 2021
  • Fig. 20 Monoclonal Antibodies in Veterinary Health Market: animal type movement analysis
  • Fig. 21 Dogs market, 2017 - 2030 (USD Million)
  • Fig. 22 Others market, 2017 - 2030 (USD Million)
  • Fig. 23 Monoclonal Antibodies in Veterinary Health Market application outlook: 2021
  • Fig. 24 Monoclonal Antibodies in Veterinary Health Market: application movement analysis
  • Fig. 25 Dermatology market, 2017 - 2030 (USD Million)
  • Fig. 26 Pain market, 2017 - 2030 (USD Million)
  • Fig. 27 Others market, 2017 - 2030 (USD Million)
  • Fig. 28 Monoclonal Antibodies in Veterinary Health Market end-user outlook: 2021
  • Fig. 29 Monoclonal Antibodies in Veterinary Health Market: end-user movement analysis
  • Fig. 30 Veterinary Hospitals market, 2017 - 2030 (USD Million)
  • Fig. 31 Others market, 2017 - 2030 (USD Million)
  • Fig. 32 Regional market place: 2021
  • Fig. 33 Regional outlook, 2017 & 2030
  • Fig. 34 North America Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 35 U.S. Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 36 Canada Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 37 Europe Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 38 U.K. Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 39 Germany Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 40 France Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 41 Italy Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 42 Spain Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 44 Japan Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 45 China Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 46 India Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 47 Australia Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 48 South Korea Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 49 Latin America Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 50 Brazil Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 51 Mexico Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 52 Argentina Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 53 MEA Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030 (USD Million)
  • Fig. 54 South Africa Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030(USD Million)
  • Fig. 55 Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2017 - 2030(USD Million)
  • Fig. 56 Strategy framework
  • Fig. 57 Market participant categorization
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!